Skip to main content
Have a personal or library account? Click to login
Prevalence of the ABCB1 NT230[DEL4] Mutation in Different Dog Breeds in Türkiye Cover

Prevalence of the ABCB1 NT230[DEL4] Mutation in Different Dog Breeds in Türkiye

Open Access
|Sep 2026

References

  1. Eichelbaum M, Fromm MF, Schwab M: Clinical aspects of the MDR1 (ABCB1) gene polymorphism. Ther Drug Monit 2004, 26(2):180–185.
  2. Lee JJ, Lin HY, Chen CA, Lin CS, Wang LC: Development of an oligonucleotide microarray for simultaneous detection of two canine MDR1 genotypes and association between genotypes and chemotherapy side effects. J Vet Sci 2019, 20(1):27–33.
  3. Mizukami K, Chang HS, Yabuki A, Kawamichi T, Hossain MA, Rahman MM, Uddin MM, Yamato O: Rapid genotyping assays for the 4-base pair deletion of canine MDR1/ABCB1 gene and low frequency of the mutant allele in Border Collie dogs. J Vet Diagn Invest 2012, 24(1):127–134.
  4. Pathan N, Shende P: Tailoring of P-glycoprotein for effective transportation of actives across blood-brain barrier. J Control Release 2021, 335:398–407.
  5. Bruckmueller H, Cascorbi I: ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding? Expert Opin Drug Metab Toxicol 2021, 17(4):369–396.
  6. Jiang B, Yan LJ, Wu Q: ABCB1 (C1236T) polymorphism affects P-glycoprotein-mediated transport of methotrexate, doxorubicin, actinomycin D, and etoposide. DNA Cell Biol 2019, 38(5):485–490.
  7. Saiz-Rodríguez M, Belmonte C, Román M, Ochoa D, Jiang-Zheng C, Koller D, Mejía G, Zubiaur P, Wojnicz A, Abad-Santos F: Effect of ABCB1 C3435T polymorphism on pharmacokinetics of antipsychotics and antidepressants. Basic Clin Pharmacol Toxicol 2018, 123(4):474–485.
  8. Virkel G, Ballent M, Lanusse C, Lifschitz A: Role of ABC transporters in veterinary medicine: pharmaco-toxicological implications. Curr Med Chem 2019, 26(7):1251–1269.
  9. Sameer AS, Banday MZ, Nissar S: Mutations and polymorphisms: what is the difference? In: Genetic Polymorphism and Cancer Susceptibility. Edited by Sameer AS, Banday MZ, Nissar S. Singapore: Springer; 2021, 1–21.
  10. Yee SW, Brackman DJ, Ennis EA, Sugiyama Y, Kamdem LK, Blanchard R, Galetin A, Zhang L, Giacomini KM: Influence of transporter polymorphisms on drug disposition and response: a perspective from the International Transporter Consortium. Clin Pharmacol Ther 2018, 104(5):803–817.
  11. Wolking S, Schaeffeler E, Lerche H, Schwab M, Nies AT: Impact of genetic polymorphisms of ABCB1 (MDR1, P-glycoprotein) on drug disposition and potential clinical implications: update of the literature. Clin Pharmacokinet 2015, 54:709–735.
  12. Hwang JG, Jeong SI, Kim YK, Lee Y, Ji SC, Lee S, Park MK: Common ABCB1 SNP, C3435T could affect systemic exposure of dapagliflozin in healthy subject. Transl Clin Pharmacol 2022, 30(4):212–225.
  13. Jeleń AM, Sałagacka A, Żebrowska MK, Mirowski M, Talarowska M, Gałecki P, Balcerczak EI: The influence of C3435T polymorphism of the ABCB1 gene on genetic susceptibility to depression and treatment response in Polish population: preliminary report. Int J Med Sci 2015, 12(12):974–979.
  14. Shen XM, Cheng J: Effects of MDR1 (C3435T) polymorphism on resistance, uptake, and efflux to antiepileptic drugs. DNA Cell Biol 2019, 38(3):250–255.
  15. Devine K, Villalobos E, Kyle CJ, Andrew R, Reynolds RM, Stimson RH, Nixon M, Walker BR: The ATP-binding cassette proteins ABCB1 and ABCC1 as modulators of glucocorticoid action. Nat Rev Endocrinol 2023, 19(2):112–124.
  16. Zdańkowski S, Gruszczyńska J, Fiszdon K, Siewruk K, Grzegrzółka B, świderek W: Drug tolerance/intolerance in domestic dog (Canis lupus familiaris) with MDR1 gene defect. Folia Pomeranae Univ Technol Stetin 2017, 332(41/1):117–126.
  17. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989.
  18. Silvestro CA, Soria LA, Conte A, Marrube G: Two methods for genotyping a 4-base deletion in the canine ABCB1 gene. J Vet Diagn Invest 2019, 31(6):889–892.
  19. Mealey KL, Bentjen SA, Gay JM, Cantor GH: Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 2001, 11(8):727–733.
  20. Geyer J, Döring B, Godoy JR, Moritz A, Petzinger E: Frequency of the nt230(del4) MDR1 mutation in Collies and related dog breeds in Germany. J Vet Pharmacol Ther 2005, 28(6):545–551.
  21. Martinez M, Modric S, Sharkey M, Troutman L, Walker L, Mealey K: The pharmacogenetics of P-glycoprotein and its role in veterinary medicine. J Vet Pharmacol Ther 2008, 31(4):285–300.
  22. Court MH: Feline drug metabolism and disposition: pharmacokinetic evidence for species differences and molecular mechanisms. Vet Clin North Am Small Anim Pract 2013, 43(5):1039–1054.
  23. Mealey KL, Owens JG, Freeman E: Canine and feline P-glycoprotein deficiency: what we know and where we need to go. J Vet Pharmacol Ther 2023, 46(1):1–16.
  24. Roberts ML: Inherent P-glycoprotein deficiency and macrocyclic lactone toxicity in an Australian Maine Coon cat homozygous for ABCB1 1930_1931delTC. JFMS Open Rep 2026, 12(1): 20551169251413335.
  25. Nürnberger D, Müller SF, Hamann M, Geyer J: First sequencing of caprine Mdr1 (ABCB1) mRNA due to suspected neurological adverse drug reaction in a Thuringian goat following extra-label use of doramectin. Front Vet Sci 2021, 8:1–9.
  26. Guo T, Huang J, Zhang H, Dong L, Guo D, Guo L, He F, Bhutto ZA, Wang L: ABCB1 in pigs: molecular cloning, tissues distribution, functional analysis, and its effect on pharmacokinetics of enrofloxacin. Sci Rep 2016, 6(1):1–12.
  27. Mahmoud NA, Mohammed EI, Elshafei SO, Elsadig AH, Omer RA, Abdalla HE, Eisa AA, Haram NA, Osman HM: Bioinformatics analysis of single nucleotide polymorphism in multiple drug resistance protein 1 (ABCB1) and multidrug resistance-associated protein 1 (ABCC1) in Bos taurus. Am J Bioinform Res 2017, 7(1):9–24.
  28. Vaidhya A, Ghildiyal K, Rajawat D, Nayak SS, Parida S, Panigrahi M: Relevance of pharmacogenetics and pharmacogenomics in veterinary clinical practice: a review. Anim Genet 2024, 55(1):3–19.
  29. Han JI, Son HW, Park SC, Na KJ: Novel insertion mutation of ABCB1 gene in an ivermectin-sensitive Border Collie. J Vet Sci 2010, 11(4):341–344.
  30. Soussa RW, Woodward A, Marty M, Cannon CM: Breed is associated with the ABCB1-1Δ mutation in Australian dogs. Aust Vet J 2020, 98(3):79–83.
  31. Galindo J, Ayala MA, Sánchez DR, Hernández C, Duifhuis T: Novel genotyping assay for the nt230(del4) ABCB1 gene mutation and its allele frequency in Border Collie dogs in Mexico. J Vet Diagn Invest 2021, 33(6):1133–1136.
  32. Marelli SP, Polli M, Frattini S, Cortellari M, Rizzi R, Crepaldi P: Genotypic and allelic frequencies of MDR1 gene in dogs in Italy. Vet Rec Open 2020, 7(1):1–5.
  33. Gramer I, Leidolf R, Döring B, Klintzsch S, Krämer EM, Yalcin E, Petzinger E, Geyer J: Breed distribution of the nt230(del4) MDR1 mutation in dogs. Vet J 2011, 189(1):67–71.
  34. Dekel Y, Machluf Y, Stoler A, Aderet A, Baumel D, Kellerman E, Plotsky Y, Noked Partouche O, Elhalal G, Ben-Shlomo I, Bercovich D: Frequency of canine nt230(del4) MDR1 mutation in prone pure breeds, their crosses and mongrels in Israel. BMC Vet Res 2017, 13(1):1–8.
  35. Tappin SW, Goodfellow MR, Peters IR, Day MJ: Frequency of the mutant MDR1 allele in dogs in the UK. Vet Rec 2012, 171(3):72.
  36. Neff MW, Robertson KR, Wong AK, Safra N, Broman KW, Slatkin M, Mealey KL, Pedersen NC: Breed distribution and history of canine mdr1-1Δ, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage. Proc Natl Acad Sci USA 2004, 101(32):11725–11730.
  37. Donner J, Anderson H, Davison S, Hughes AM, Bouirmane J, Lindqvist J, Lytle KM, Ganesan B, Ottka C, Ruotanen P, Kaukonen M, Forman OP, Fretwell N, Cole CA, Lohi H: Frequency and distribution of 152 genetic disease variants in over 100,000 mixed breed and purebred dogs. PLoS Genet 2018, 14(4):e1007361.
  38. Mealey KL, Meurs KM: Breed distribution of the ABCB1-1Δ (multidrug sensitivity) polymorphism among dogs undergoing ABCB1 genotyping. J Am Vet Med Assoc 2008, 233(6):921–924.
  39. Pires AR, Gerardi D, Tisotti TM, Serpa PBS, Natalini CC: First report of nt230(del4) mutation in the MDR1 gene in German Shepherds in Southern Brazil. Cienc Rural 2021, 51(10):1–5.
  40. Siegl L, Bethäuser M, Nürnberger D, Oswald S, Moritz A, Hamann M, Geyer J: Functional characterization of the cat and dog wild-type and mutant MDR1 carrier proteins and frequency of the MDR1 gene mutation in 800 cats from Germany. J Vet Pharmacol Ther 2026, 49(3):237–256.
  41. Baydan E, Cınar Kul B, Akkurt MY, Yıldırım E, Arslanbaş E, Aydın FG: Investigation of ivermectin susceptibility in Kangal and Akbaş dogs via MDR1 gene mutation. Harran Univ J Fac Vet Med 2024, 13(1):1–7.
  42. Beckers E, Casselman I, Soudant E, Daminet S, Paepe D, Peelman L, Broeckx BJG: The prevalence of the ABCB1-1Δ variant in a clinical veterinary setting: the risk of not genotyping. PLoS One 2022, 17(8):e0273706.
  43. Fromm MF: Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci 2004, 25(8):423–429.
  44. Malki MA, Pearson ER: Drug-drug-gene interactions and adverse drug reactions. Pharmacogenomics J 2020, 20(3):355–366.
DOI: https://doi.org/10.2478/acve-2026-0028 | Journal eISSN: 1820-7448 | Journal ISSN: 0567-8315
Language: English
Page range: 409 - 422
Submitted on: Jun 19, 2026
Accepted on: Aug 17, 2026
Published on: Sep 13, 2026
Published by: University of Belgrade, Faculty of Veterinary Medicine
In partnership with: Paradigm Publishing Services
Related subjects:

© 2026 Meryem Toprak Tuncer, Merve Yüksel, Bilgenur Korkut, Ahmet Ateşşahin, published by University of Belgrade, Faculty of Veterinary Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.